← Back to Search

Antiparasitic

Nitazoxanide for Cryptosporidiosis in AIDS

N/A
Waitlist Available
Research Sponsored by Romark Laboratories L.C.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients aged 3 to 65 years old (consent of parent or guardian required if under 18)
Patients testing positive for the parasite Cryptosporidium and experiencing severe diarrhea (at least 4 bowel movements per day) for at least 2 weeks
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Study Summary

This trial will test whether nitazoxanide can treat diarrhea in AIDS patients caused by the Cryptosporidium parasite.

Who is the study for?
This trial is for AIDS patients aged 3 to 65 with severe diarrhea due to Cryptosporidium. Eligible participants must have a CD4 count ≤200 cells/mm3, or >200 if they've had cryptosporidiosis for over 4 weeks. They should have tried treatments but got reinfected. Exclusions include pregnancy, other parasite infections, specific intestinal diseases, and recent use of certain medications.Check my eligibility
What is being tested?
The study tests whether nitazoxanide (NTZ) can effectively treat cryptosporidiosis in AIDS patients. It aims to see if NTZ can reduce the severity of diarrhea caused by the Cryptosporidium parasite.See study design
What are the potential side effects?
While not specified here, common side effects of nitazoxanide may include stomach pain, nausea, vomiting, headache and urine discoloration. Side effects vary from person to person.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 3 and 65 years old. If under 18, I have parental consent.
Select...
I have severe diarrhea due to Cryptosporidium for over 2 weeks.
Select...
I was treated for cryptosporidiosis but got reinfected.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Find a Location

Who is running the clinical trial?

Romark Laboratories L.C.Lead Sponsor
28 Previous Clinical Trials
12,807 Total Patients Enrolled
1 Trials studying Cryptosporidiosis
30 Patients Enrolled for Cryptosporidiosis

Media Library

Nitazoxanide (Antiparasitic) Clinical Trial Eligibility Overview. Trial Name: NCT00002158 — N/A
Cryptosporidiosis Research Study Groups:
Cryptosporidiosis Clinical Trial 2023: Nitazoxanide Highlights & Side Effects. Trial Name: NCT00002158 — N/A
Nitazoxanide (Antiparasitic) 2023 Treatment Timeline for Medical Study. Trial Name: NCT00002158 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment limited to those of a younger age demographic?

"This trial is open to patients who are above 3 years of age and below 65 years."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis
2024. "A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00002158.
All > Hiv Infection
~233 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top